Skip to search boxSkip to navigationSkip to main content

Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus

  • Esophageal Cancer Study Group Participating Centers
  • Unknown
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

<p>Objective: Clinical T2N0 esophageal carcinoma is a heterogenous disease frequently complicated by inaccurate staging. Incorrect staging may lead to suboptimal treatment for patients with unidentified local-regionally advanced disease. Therapeutic options for these patients remain controversial. We sought to evaluate the outcomes of patients with cT2N0 who underwent esophagectomy as either primary therapy or after neoadjuvant treatment. Methods: This was a multi-institutional collaboration of 26 high-volume esophageal centers. Patients with complete staging who underwent elective resection from 2002 to 2012 were included. Three treatment groups were identified; primary esophagectomy, preoperative chemotherapy, and preoperative chemoradiation (CXRT). Pretreatment variables were explored for independent predictors of long-term outcomes. The primary esophagectomy subgroup was evaluated for stage migration. Results: In total, 767 patients were evaluated; 35% (268) had preoperative therapy (195 CXRT, 73 chemotherapy). Staging accuracy was 14% (70/499), with pT < 2 identified in 45% (222) and pN > 0 in 39% (195). Preoperative treatment modality (none, CXRT, chemotherapy) was not identified as a predictor of outcome (median survival 63, 70, 71 months, respectively, P =.956). Longitudinal tumor length >3.25 cm was predictive of pN+ for the primary esophagectomy cohort as well as adenocarcinoma histology only (odds ratio 2.2 and 2.4, respectively, P <.001). Conclusions: Current treatment options for patients with cT2N0M0 do not reveal a comparative survival advantage to preoperative therapy. Pretreatment tumor length can identify a subgroup of patients at risk for understaging (pN+). The incidence of overstaging suggests that organ-sparing approaches (endoscopic resection) may play a future role in appropriately selected patients.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 1264-1272.e6

Journal (Volume, Issue Number)

Journal of Thoracic and Cardiovascular Surgery (Volume 157, Issue 3)

Publication milestones

  • Published - 03/2019

Publication status

Published - 03/2019

ISSN

0022-5223

Publication IDs

  • Scopus: 85058517712
  • PubMed: 30558879

Publication metrics

Metrics

Fractional count
1
Fractional count
0.03
Fractional count
39
Fractional count
0.98
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
30
Captures
27

Funding Details

Funding for this work was provided by the Department of Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center .
FundersFunding numbers
Department of Thoracic and Cardiovascular Surgery
-
University of Texas M.D. Anderson Cancer Center
-